Cambridge Life Sciences has invested in the research and development of
biosensors systems, with particular emphasis
on Platinised Activated Carbon
Electrodes (PACE) for the Medical Diagnostics
Arena since 1986.
- Widely developing the technology.
- Collaborating in research programmes with a number of major diagnostic companies.
- Licensing its application in the measurement of analytes in a range of clinical areas.
The combination of strip immunodiagnostics and impedance sensing has enabled us to develop
a generic immunosensor
device for the quantitative detection and measurement
of different analytes. The range of applications
is broad, from cardiac diagnosis to oncology,
simply by modifying the biological/biochemical
for further information.